Total Payments
$2,979
2024 Payments
$1,148
Companies
25
Transactions
160
Medicare Patients
958
Medicare Billing
$84,702
Payment Breakdown by Category
Food & Beverage$2,966 (99.5%)
Education$13.52 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,966 | 159 | 99.5% |
| Education | $13.52 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $462.92 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $386.11 | 18 | $0 (2024) |
| Novo Nordisk Inc | $377.80 | 23 | $0 (2024) |
| ABBVIE INC. | $284.20 | 15 | $0 (2024) |
| GlaxoSmithKline, LLC. | $217.90 | 12 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $171.67 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $118.11 | 5 | $0 (2023) |
| Exact Sciences Corporation | $117.87 | 7 | $0 (2024) |
| Astellas Pharma US Inc | $114.30 | 7 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $112.12 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,148 | 62 | Novo Nordisk Inc ($246.46) |
| 2023 | $1,193 | 60 | Lilly USA, LLC ($184.23) |
| 2022 | $627.68 | 37 | Lilly USA, LLC ($82.35) |
| 2020 | $11.27 | 1 | GlaxoSmithKline, LLC. ($11.27) |
All Payment Transactions
160 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Diabetes | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Obesity | ||||||
| 11/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Oncology | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.51 | General |
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: UROLOGY | ||||||
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Obesity | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $17.14 | General |
| 09/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/27/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.26 | General |
| 08/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Obesity | ||||||
| 08/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 392 | 519 | $106,667 | $36,827 |
| 2022 | 14 | 515 | 592 | $125,611 | $42,556 |
| 2021 | 3 | 51 | 52 | $15,690 | $5,319 |
Total Patients
958
Total Services
1,163
Medicare Billing
$84,702
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 177 | $46,020 | $13,378 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 61 | 61 | $17,995 | $7,450 | 41.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $10,860 | $5,063 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 83 | $14,525 | $4,331 | 29.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 25 | 25 | $4,125 | $1,819 | 44.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 22 | 29 | $5,450 | $1,813 | 33.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $2,006 | $991.78 | 49.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 22 | 26 | $2,990 | $920.42 | 30.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $1,121 | $554.23 | 49.4% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 13 | 19 | $665.00 | $266.00 | 40.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 22 | 26 | $910.00 | $239.42 | 26.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 86 | 86 | $25,370 | $10,675 | 42.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 109 | $28,340 | $9,217 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $24,490 | $6,119 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 89 | $15,575 | $4,917 | 31.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 20 | 20 | $8,900 | $3,091 | 34.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 39 | 39 | $6,435 | $2,740 | 42.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 30 | 33 | $5,775 | $1,820 | 31.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 52 | 52 | $3,068 | $1,459 | 47.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 19 | 23 | $2,645 | $1,004 | 37.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 12 | 16 | $2,720 | $646.73 | 23.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $649.00 | $309.01 | 47.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 14 | 14 | $686.00 | $293.73 | 42.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 18 | 24 | $832.00 | $220.44 | 26.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 14 | 14 | $126.00 | $44.80 | 35.6% |
About Dr. Rutwik Patel, MD
Dr. Rutwik Patel, MD is a Internal Medicine healthcare provider based in Reidsville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2018. The National Provider Identifier (NPI) number assigned to this provider is 1952899049.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rutwik Patel, MD has received a total of $2,979 in payments from pharmaceutical and medical device companies, with $1,148 received in 2024. These payments were reported across 160 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,966).
As a Medicare-enrolled provider, Patel has provided services to 958 Medicare beneficiaries, totaling 1,163 services with total Medicare billing of $84,702. Data is available for 3 years (2021–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Reidsville, NC
- Active Since 04/25/2018
- Last Updated 08/03/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1952899049
Products in Payments
- MOUNJARO (Drug) $276.26
- VRAYLAR (Drug) $188.00
- JARDIANCE (Drug) $186.81
- FARXIGA (Drug) $172.01
- TRELEGY ELLIPTA (Drug) $165.49
- REXULTI (Drug) $157.12
- Wegovy (Drug) $137.20
- NURTEC ODT (Drug) $133.44
- AIRSUPRA (Drug) $126.45
- Cologuard Collection Kit (Device) $117.87
- Ozempic (Drug) $110.77
- Veozah (Drug) $99.01
- Otezla (Drug) $83.65
- GVOKE HYPOPEN (Drug) $74.79
- Kerendia (Drug) $61.32
- LOKELMA (Drug) $56.61
- Rybelsus (Drug) $44.71
- XIFAXAN (Drug) $44.54
- QUVIVIQ (Drug) $41.56
- RINVOQ (Biological) $41.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Reidsville
Dr. John Hall, M.d, M.D
Internal Medicine — Payments: $25,300
Internal Medicine $25,300
Lawrence Fusco, M.d, M.D
Internal Medicine — Payments: $4,054
Internal Medicine $4,054
Dr. Samuel Mcdowell, M.d, M.D
Internal Medicine — Payments: $2,992
Internal Medicine $2,992
Charles Carver, D.o, D.O
Internal Medicine — Payments: $2,037
Internal Medicine $2,037
Phillip Dixon, Md, MD
Internal Medicine — Payments: $1,409
Internal Medicine $1,409
Dr. Najeeb Rehman, Md, MD
Internal Medicine — Payments: $1,317
Internal Medicine $1,317